To view or add a comment, sign in Aerska raises $21M to drive novel RNAi therapies for neurological diseases, aiming to overcome the blood-brain barrier with precision delivery
The National Institutes of Health clearly agrees
Food and Drug Administration, news release, July 26, 2024 What This Means For You People should avoid taking compounded semaglutide products, or make sure they are given the drug in proper measurements and dosages.
Moving forward, the research community should prioritize properly designed human clinical trials examining BPC-157 in conditions with strong preclinical evidence and unmet clinical needs
This may require protein supplementation since whole food protein sources are filling and difficult to consume in large quantities
Many patients are able to return to work with no restrictions